Comparison of Endoscopic Lumbar Decompression and Minimally Invasive Transforaminal Lumbar Interbody Fusion(MIS-TLIF) for Degenerative Lumbar Spondylolisthesis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorQueen Savang Vadhana Memorial Hospital, Thailand

About this trial

Comparing the functional and radiographic outcomes in surgical treatment in failed conservative treatment, single-level low grade degenerative lumbar spondylolisthesis between Minimal Invasive Surgery Transforaminal Lumbar Interbody Fusion, which is conventional treatment recently, and Endoscopic Lumbar Decompression, which is minimal invasive in symptomatic treatment.

Eligibility criteria

Qualifiers

Single level lumbar degenerative spondylolisthesis (Meyerding Grading Grade I or II).

Failed conservative treatment for at least 3 months.

No instability evidence of levels of lesion (Consideration from translation more than 5 mm or angulation change more than 10 degree in flexion and extension L-S plain films ).

Able to follow up for at least 12 months.

Disqualifiers

Patients with severe foraminal stenosis diagnosed by MRI.

Patients who have previously undergone lumbar spine surgery (revision surgery).

Patients with other abnormalities in the lumbar spine, such as infection, tumors, or fractures.

Patients who cannot undergo surgery due to underlying conditions or who cannot maintain the prone position for extended periods.

Trial design

Treatments tested in this trial

  • Lumbar Endoscopic - Unilateral Laminotomy for Bilateral Decompression

Treatment groups

66 Participants
are divided into 2 treatment groups